Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01674140
Title S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Southwest Oncology Group
Indications

Her2-receptor negative breast cancer

Therapies

Goserelin

Anastrozole

Letrozole

Leuprolide

Everolimus

Tamoxifen

Exemestane

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.